Over time, during the aging process, we lose physiological volumes, including adipose tissue.
LIPOGENETIC uses the biological principle according to which an excessive increase in the volume of adipocytes leads to the activation of immobile adipose stem cells.
Previously, to activate the lipogenesis process, it was necessary to manually prepare a drug for its activation. For this, 1 ml of a 5% glucose solution was to be mixed with fast insulin.
Accumulation of triglycerides causes an increase in cell volume due to an increase in intra-dipocyte vacuoles. An adipocyte is able to significantly increase its volume to collect energy in the form of triglycerides. But when its volume is very large (over 170% of normal volume), the adipocyte stimulates the formation of new adipose tissue. The stimulus to mitosis and the differentiation of the preadipocytes mainly follows an increase in the insulin rate due to the suppression of the hypertrophied adipocyte receptor and the release of IGF-1.
LIPOGENETIC has been developed to make the lipogenesis procedure more practical, faster and easier. Replaces insulin IGF-1, necessary for the stimulation of adipose tissue stem cells and acts on the same receptor for intracellular insulin. IGF-1, studied for amino acid composition, is synthesized in the laboratory. The composition also contains isobutylmethylxanthine, capable of activating the PPAR range different from insulin, which in turn activates adipogenesis and the formation of new adipocytes.
The drug is absolutely safe.
LIPOGENETIC is useful to physiologically replace fillers. Once the maximum physiological volume of adipose tissue has been reached, the mechanotransduction processes allowed by the matrix / cell compound will regulate the multiplication of adipocytes to maintain a constant volume.
During the regeneration of adipose tissue, we use a direct activation session (ROS) every three months and indirectly, once a month.
Lipogenesis can also be used in all areas where it is necessary to regenerate adipose tissue:
– normalizes the physiological volume of the breast, which has lost its shape due to aging or weight loss. The mechanotransduction process will support a physiological, genetically determined volume.
– it is possible to correct undulatory irregularities after the mastoplasty.